Drug Shortage Report for TEVA-PROGESTERONE
Report ID | 132633 |
Drug Identification Number | 02439913 |
Brand name | TEVA-PROGESTERONE |
Common or Proper name | PROGESTERONE 100MG CAP |
Company Name | TEVA CANADA LIMITED |
Market Status | MARKETED |
Active Ingredient(s) | PROGESTERONE |
Strength(s) | 100MG |
Dosage form(s) | CAPSULE |
Route of administration | ORAL ORAL |
Packaging size | 100 |
ATC code | G03DA |
ATC description | PROGESTOGENS |
Reason for shortage | Disruption of the manufacture of the drug. |
Anticipated start date | |
Actual start date | 2021-01-26 |
Estimated end date | 2021-02-28 |
Actual end date | 2021-03-17 |
Shortage status | Resolved |
Updated date | 2021-03-18 |
Company comments | |
Health Canada comments | |
Tier 3 Status | No |
Contact Address | 30 NOVOPHARM COURT TORONTO, ONTARIO CANADA M1B 2K9 |
Company contact information |
Version History
Click on "Compare" below to view the full report history and compare to other versions.
Version Number | Date Updated | Language | |
---|---|---|---|
v1 | 2021-01-28 | English | Compare |
v2 | 2021-01-28 | English | Compare |
v3 | 2021-01-28 | French | Compare |
v4 | 2021-03-04 | English | Compare |
v5 | 2021-03-04 | French | Compare |
v6 | 2021-03-18 | English | Compare |
v7 | 2021-03-18 | French | Compare |
Showing 1 to 7 of 7